期刊文献+

应用假病毒和假型病毒制备抗猪瘟病毒E2蛋白中和性单克隆抗体的初步研究 被引量:4

Development of neutralizing monoclonal antibody against E2 protein of CSFV by using pseudovirus and pseudotyped virus
在线阅读 下载PDF
导出
摘要 为制备抗猪瘟病毒(CSFV)单克隆抗体(MAb),本实验以表达CSFV E2囊膜糖蛋白的水泡口炎假病毒免疫BALB/c小鼠,取其脾细胞与骨髓瘤细胞SP2/0进行融合;利用间接ELISA方法和携带荧光素酶(Luciferase)报告基因的HIV-luc/CSFV-E1&E2假病毒系统筛选分泌中和性E2MAb的杂交瘤细胞;测定MAb亚型并纯化后,间接ELISA方法测定MAb的效价;采用western blot鉴定MAb的特异性亲和力;利用HIV-luc/CSFV-E1&E2假病毒进行体外中和试验,分析MAb抑制病毒感染的能力。结果表明本实验获得了1株分泌中和性MAb的杂交瘤细胞9C8,该MAb能与E2蛋白特异性结合,而且体外抑制试验中和效价大于1∶25600。 To prepare E2 neutralizing monoclonal antibody(MAb) against classical swine fever virus(CSFV) ,BALB/c mice were immunized with recombinant vesicular stomatitis virus(rVSV) expressing the envelope glycoprotein E2 of CSFV;mouse splenic cells were fused with SP2/0 cells and hybridoma cells were screened by indirect ELISA and retroviral pseudotype virus HIV-luc/CSFV bearing CSFV E1 and E2 glycoproteins. The specificity and the antigen-binding activity of the MAb were identified by indirect ELISA and western blot,and neutralizing activity against CSFV was measured as inhibitions of luciferase reporter gene by pseudotype neutralization assay. One hybridoma(9C8) secreting neutralizing MAb against CSFV was successfully obtained;The MAb showed specificity against the E2 protein and had a neutralization titre more than 1∶25 600.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2010年第4期289-293,共5页 Chinese Journal of Preventive Veterinary Medicine
关键词 猪瘟病毒 中和性单克隆抗体 假病毒 中和试验 CSFV neutralizing monocolonal antibody pseudotyped virus neutralization assay
  • 相关文献

参考文献16

  • 1Francki R I,Fanquet C M,Knudson D L,et al.Flaviviridae Arch[J].Virology (Suppl),1991,2:223-233.
  • 2殷霞,刘景华.动物病毒学[M].2版.北京:科学出版社,1998.
  • 3Dong X N,Qi Y,Ying J,et al.Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2[J].Vaccine,2006,26(4):426-434.
  • 4Wang Z,Nie Y C,Wang P G,et al.Characterization of classical swine fever virus entry by using pseudotyped viruses:ElandE2 are sufficient to mediate viral entry[J].Virology 2004,330:332-334.
  • 5Kosmidou A,Thiel H J,Weiland E,et al.Differentiation of classical swine fever virus (CSFV) strains using monoclonal antibodies against structural glycoproteins[J].Vet Microbiol.1995,47(1-2):111-8.
  • 6Van Rijn P A,Miedema G K,Wensvoort G,et al.Antigenic structure of envelope glycoprotein E1 of hog cholera virus[J].J.Virol.1994,68:3934-3942.
  • 7R ü menapf T,Meyers G,Thiel H J.Structural proteins of hog cholera virus expressed by vaccinia virus:further characterization and induction of protective immunity[J].Virology,1991,65(2):589-597.
  • 8Van Zijl M,Hulst M,Moormann R.Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera[J].Virology,1991,65(5):2761-2765.
  • 9Rose N,Marx P,Rose J K.An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants[J].Cell,2001,106(5):539-549.
  • 10Kapadia S U,Rose J K,Lamirande E,et al.Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine[J].Virology,2005,340:174-182.

共引文献441

同被引文献46

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部